Copyright
©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Mar 10, 2016; 8(5): 252-258
Published online Mar 10, 2016. doi: 10.4253/wjge.v8.i5.252
Published online Mar 10, 2016. doi: 10.4253/wjge.v8.i5.252
New era of colorectal cancer screening
Maysaa El Zoghbi, Linda C Cummings, Division of Gastroenterology and Liver Disease, University Hospitals Case Medical Center, Cleveland, OH 44106-5066, United States
Author contributions: El Zoghbi M and Cummings LC contributed equally to this paper.
Supported by An American College of Gastroenterology Junior Faculty Development Award to Linda C Cummings.
Conflict-of-interest statement: None.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Maysaa El Zoghbi, MD, Gastroenterology Fellow, Division of Gastroenterology and Liver Disease, University Hospitals Case Medical Center, 11000 Euclid Avenue, Cleveland, OH 44106-5066, United States. maysaa.elzoghbi@uhhospitals.org
Telephone: +1-216-8445386 Fax: +1-216-9830347
Received: April 30, 2015
Peer-review started: May 7, 2015
First decision: July 17, 2015
Revised: October 24, 2015
Accepted: December 29, 2015
Article in press: January 1, 2016
Published online: March 10, 2016
Processing time: 309 Days and 1.4 Hours
Peer-review started: May 7, 2015
First decision: July 17, 2015
Revised: October 24, 2015
Accepted: December 29, 2015
Article in press: January 1, 2016
Published online: March 10, 2016
Processing time: 309 Days and 1.4 Hours
Core Tip
Core tip: Multiple societies have issued screening guidelines for colorectal cancer (CRC). However, global CRC screening implementation can be challenging due to wide variability in healthcare infrastructure and resources in different countries. The practical implementation of CRC screening in a given area depends mainly upon availability of endoscopic resources. In areas with the greatest healthcare resources, colonoscopy remains the gold standard, although technological advances have provided alternative screening methods including computed tomographic colonography, fecal DNA testing, and colon capsule endoscopy. In areas with fewer healthcare resources, guaiac-based fecal occult blood testing is the predominant screening modality.